日本血吸虫SjRAD23基因的克隆表达及基因重组抗原的免疫保护效果

辐射敏感蛋白23具有核苷酸切除修复功能,在泛素蛋白酶体途径中起到重要作用。本研究利用PCR技术克隆了日本血吸虫辐射敏感蛋白23(Sj RAD23)编码的c DNA序列,成功获得Sj RAD23的基因序列,其ORF为1 053 bp。构建Sj RAD23基因重组表达质粒p ET28a(+)-Sj RAD23,并在大肠杆菌BL21中成功诱导表达,重组蛋白在上清和沉淀中都有存在。利用免疫组化技术检测该蛋白在虫体的分布情况,该蛋白广泛分布在日本血吸虫虫体被膜。用重组蛋白免疫BALB/c小鼠后,免疫小鼠血清中检测到较高水平的特异性Ig G、Ig G1和Ig G2a。Western blotting分析显示重组蛋白能够被日本血吸虫成虫可溶性抗原免疫小鼠血清所识别。用重组蛋白r Sj RAD23免疫结果与206佐剂对照组比较,r Sj RAD23在BALB/c小鼠中诱导了35.94%减虫率,40.59%肝脏减卵率。结果表明Sj RAD23具有作为疫苗候选分子的潜力。     

日本血吸虫Sj Cyclophilin B基因的克隆、表达及免疫保护效果分析

本研究克隆和表达了日本血吸虫Cyclophilin B(Sj CyPB)编码基因的cDNA,分析其在日本血吸虫不同发育阶段虫体的表达情况,评估该重组抗原在小鼠体内诱导的抗血吸虫免疫保护效果。本研究以日本血吸虫童虫cDNA为模板,RT-PCR扩增其基因全长cDNA,提交序列到NCBI,登录号为GQ403665。荧光实时定量PCR分析该基因在日本血吸虫不同发育阶段虫体的表达情况,构建重组表达质粒,表达纯化重组蛋白。利用Western blotting检测重组蛋白的抗原性。以重组抗原免疫小鼠,评估其对小鼠诱导的免疫保护效果。结果表明,RT-PCR获得了Sj CyPB编码基因的全长cDNA,其开放阅读框为672bp。经分析确定其为CyPs家族中的CyPB基因,命名为Sj CyPB。荧光实时定量PCR分析表明,该基因在18d童虫期表达量最高,32d次之。构建了重组表达质粒pGEX-6P-1-SjCyPB,并在大肠杆菌中成功表达,表达产物分子量为49.5kDa。Western blotting试验显示该重组蛋白具有良好的抗原性,在小鼠免疫试验中,与空白对照组比较,免疫组小鼠获得31.5%的减虫率和41.01%的肝脏减卵率。本研究获得了日本血吸虫童虫期高表达的Sj CyPB基因的全长cDNA,成功构建了Sj CyPB原核重组表达质粒,并在大肠杆菌中成功表达,证实该重组抗原在小鼠体内诱导产生了部分免疫保护效果。     

日本血吸虫SjOST48基因的克隆、表达及其重组蛋白免疫保护效果分析

为了鉴定日本血吸虫SJCHGC01743基因并评估其重组蛋白作为新的血吸虫病候选疫苗抗原的潜力,利用PCR技术扩增日本血吸虫SJCHGC01743基因,应用荧光实时定量PCR分析该基因在日本血吸虫不同发育阶段虫体的转录水平,以p ET-28a(+)为载体构建重组表达质粒并诱导其在大肠杆菌中表达。将纯化的重组蛋白免疫BALB/c小鼠制备免疫血清,利用Western blotting检测重组蛋白的免疫原性,应用间接免疫荧光技术对SJCHGC01743进行蛋白组织定位,利用间接ELISA方法检测小鼠血清中特异性抗体水平。将重组抗原免疫小鼠,评估其免疫保护效果。PCR扩增得到1 248 bp不含信号肽的c DNA序列,同源性分析结果显示,该基因为日本血吸虫寡糖转移酶OST48亚基,命名为Sj OST48。实时定量PCR分析显示Sj OST48在检测的童虫和成虫各个期别虫体中均有转录,其中在28 d虫体中的转录水平最高,在42 d雌虫中的转录量显著高于雄虫。构建的重组表达质粒p ET-28a(+)-Sj OST48成功在大肠杆菌中表达,重组蛋白r Sj OST48分子量约50 k Da。Western blotting分析表明r Sj OST48能被小鼠免疫血清识别,具有良好的免疫原性,间接免疫荧光实验表明Sj OST48蛋白主要分布于虫体体被,少量分布于实质。ELISA检测结果表明r Sj OST48能诱导产生较高的特异性Ig G、Ig G1和Ig G2a抗体。动物免疫保护实验结果表明Sj OST48能诱导小鼠产生32.62%(P0.05)的减虫率及57.61%(P0.01)的肝脏减卵率。本研究为深入探讨日本血吸虫Sj OST48基因的生物学功能及筛选新的血吸虫疫苗候选分子奠定了基础。     

日本血吸虫蛋白酶体α2亚基基因的克隆、表达及功能分析

26S蛋白酶体是一种能够降解大多数内源性蛋白的多亚基复合物,它的蛋白降解作用能够影响细胞周期、转录控制和其他一些重要的细胞进程。本实验利用PCR技术从日本血吸虫18d童虫中首次扩增到蛋白酶体α2亚基基因(GenBank Accession No.AY813725),序列分析表明该基因的开放阅读框(ORF)含708bp,编码235个氨基酸,理论分子量25.84kDa。同源性分析结果显示,该基因为日本血吸虫蛋白酶体α2亚基,命名为SjPSMA2。实时定量PCR分析显示该基因在7d、13d、18d、23d、32d和42d虫体中都有表达,7d和23d虫体表达量低于其他几个时期。构建了该基因的原核表达质粒pET28a(+)-SjPSMA2,在大肠杆菌系统中成功获得了表达,重组蛋白以包涵体形式存在,Western blotting显示表达产物能被日本血吸虫成虫粗抗原免疫血清所识别,并且能检测到天然状态下该蛋白的存在。应用重组蛋白免疫BALB/c小鼠后,诱导产生了较高的特异性抗体水平及12.33%的减虫率和35.23%的肝脏减卵率。SjPSMA2基因及其表达产物的获得,为探索蛋白酶体在血吸虫生长发育中的作用提供了重要基础。     

日本血吸虫脂肪酸结合蛋白基因的克隆及其在大肠杆 …

用ＰＣＲ法从日本血吸虫中国大陆株成虫ｃＤＮＡ文库中快速克隆出一大小为６００ｂｐ左右的ＤＮＡ片段,ＤＮＡ序列分析证实,所扩增到的ＤＮＡ片段中含有日本血吸虫脂肪酸结合蛋白（Ｓｊ－１４ＦＡＢＰｃ）基因,将该基因重组到表达型质粒ｐＧＥＸ－２Ｔ中,表达的ＧＳＴ融合蛋白分子量是４１ｋＤ,用谷胱甘肽琼脂糖凝胶亲和层析柱纯化的重组蛋白不仅纯度好,而且得率高,纯化产量可达２５ｍｇ／Ｌ培养物,免疫试验结果表明该重组蛋     

日本血吸虫新基因Sj-MA的克隆、表达及保护性免疫

为发现新基因 ,寻找日本血吸虫病新疫苗候选分子 ,采用Sj雄虫免疫血清筛选Sj成虫cDNA文库。经测序发现新基因Sj MA含有一个完整的阅读框 ,推测其由 2 4 9个氨基酸组成 ,编码分子量为 2 8.8kD的可溶性蛋白质 ,并带有多个能被磷酸化激活的位点 ,提示其可能为一重要的信息传递分子。将Sj MA的cDNA亚克隆至原核表达载体pGEX 5X ,获得Sj MA原核表达的重组体rSj MA/GST ,并在E .coli中高效表达为谷胱甘肽S 转移酶 (GST)融合蛋白 ,分子量为 5 4 .8kD ,Western印迹显示融合蛋白质能被抗雄虫和抗GST血清识别。融合蛋白质免疫小鼠可诱导 34.2 9%的减虫率 ,与对照组有显著性差异 (P <0 .0 0 1 )。表明新基因Sj MA表达的蛋白质能诱导小鼠的抗日本血吸虫的保护性免疫 ,提示其作为日本血吸虫疫苗候选分子的潜在价值     

用日本血吸虫部分cDNA表达质粒文库免疫小鼠产生的保护性效果

寻找保护性效果更好的抗原分子一直是抗血吸虫病疫苗研发领域的热点和难点。国内外筛选日本血吸虫 (Ｓｃｈｉｓｔｏ ｓｏｍａｊａｐｏｎｉｃｕｍ)保护性抗原分子采取的主要策略有 2种 :一是通过构建血吸虫某一生活史ｃＤＮＡ文库 ,采用探针 (核酸或抗体 )从文库或文库表达产物中筛选出特异性抗原基因 ,再逐一评估其保护性效果。该策略的主要缺陷是筛选操作费时费力 ,且效率不高。另一途径则是根据已知的曼氏血吸虫或其它种 (株 )保护性抗原基因序列 ,通过ＰＣＲ或核酸探针等技术筛选与之同源的相应抗原分子 ,这一方法 (尤其是ＰＣＲ方法 )尽…     

日本血吸虫真核翻译起始因子5基因的cDNA克隆和免疫保护功能分析

利用抑制削减杂交法筛选日本血吸虫雌雄虫差异基因,从中获得真核翻译起始因子5基因(eIF5)的 表达序列标。对该序列进行生物信息学分析:对其5’端进行电子延伸,获得含完整开放阅读框的cDNA序列 (AY686501)。将其亚克隆到表达载体pET-28c,进行重组表达。免疫保护效果实验表明,重组表达蛋白具有显著 抑制血吸虫卵在寄主肝脏中的沉积效果。     

日本血吸虫信号转导蛋白Sjwnt-4基因的克隆、表达及功能分析

由Wnt基因家族产物与其它相关基因产物构成的Wnt信号通路,是细胞发育和生长调节的一个关键途径,对动物的发育特别是生殖系统的发育起重要的调节作用。在人类和小鼠中,Wnt4蛋白是性腺分化过程中主要调节因子,在胚胎发育中起着关键作用。利用RACE技术从日本血吸虫19d童虫中首次扩增到一个Wnt家族基因,序列分析表明该基因的完整编码框含1311bp,编码436个氨基酸,理论分子量49.6kD。同源性分析结果表明,该基因的氨基酸序列具有典型Wnt家族蛋白特征,与日本三角涡虫、人Wnt4的氨基酸序列相似性分别达43%、37%,推测为血吸虫的Wnt4基因,命名为Sjwnt4(GenBank登陆号DQ643829)。实时定量PCR分析显示该基因在14d童虫、19d童虫、31d虫体、44d雌虫及44d雄虫中均有表达,其中19d童虫中的表达量明显高于其它发育阶段,44d雌虫中的表达量明显高于雄虫。构建了该基因的原核表达载体pGEX-4T-2-Sjwnt4,应用大肠杆菌系统进行了表达,表达蛋白以包涵体形式存在,Western印迹显示表达产物能被日本血吸虫成虫粗抗原免疫血清所识别。Sjwnt4基因及其表达产物的获得,为探索Wnt信号通路对血吸虫发育、生殖的调节提供了重要基础。     

日本血吸虫脂肪酸结合蛋白基因的克隆及其在大肠杆菌中的表达

用ＰＣＲ法从日本血吸虫中国大陆株成虫ｃＤＮＡ文库中快速克隆出一大小为６００ｂｐ左右的ＤＮＡ片段,ＤＮＡ序列分析证实,所扩增到的ＤＮＡ片段中含有日本血吸虫脂肪酸结合蛋白（Ｓｊ－１４ＦＡＢＰｃ）基因,将该基因重组到表达型质粒ｐＧＥＸ－２Ｔ中,表达的ＧＳＴ融合蛋白分子量是４１ｋＤ,用谷胱甘肽琼脂糖凝胶亲和层析柱纯化的重组蛋白不仅纯度好,而且得率高,纯化产量可达２５ｍｇ／Ｌ培养物,免疫试验结果表明该重组蛋白具有良好的抗原性,为其用作疫苗分子创造了条件。     

Characterization, evolution and tissue-specific expression of AmphiCalbin, a novel gene encoding EF-hand calcium-binding protein in amphioxus Branchiostoma belcheri

An amphioxus full-length cDNA, AmphiCalbin, encoding a novel EF-hand calcium-binding protein （EFCaBP）, was isolated from the gut cDNA library of amphioxus Branchiostoma belcheri. It consists of 1321 bp with a 636 bp open reading frame encoding a protein of 211 amino acids with a molecular mass of approximately 24.5 kDa. The phylogenetic analysis offers two interesting inferences. First, AmphiCalbin clusters with a group of unnamed EFCaBPs that are differentiated from other identified EFCaBPs. Second, AmphiCalbin falls at the base of the vertebrate unnamed EFCaBPs clade, probably representing their prototype. This is also corroborated by the fact that AmphiCalbin has an exon-intron organization identical to that of vertebrate unnamed EFCaBP genes. Both tissue-section in situ hybridization and whole-mount in situ hybridization prove a tissue-specific expression pattern of AmphiCalbin, with high levels of expression in the digestive system and gonads. It is proposed that AmphiCalbin might play a role in the digestive system and gonads. These observations lay the foundation for further understanding of the function of the unnamed EFCaBPs.     

Immunization of mice with cells from juvenile worms of Schistosoma japonicum provides immunoprotection against schistosomiasis

To validate the protective efficacy against schistosomiasis by immunization with cells from juvenile Schistosoma japonicum in a murine model and to analyze possible factors related to protection, in this study, two independent repeated vaccination trials were performed. After three subcutaneous vaccina- tions, in trial one, in the absence of adjuvant, primary juvenile worm cells (pJCs) from S. japonicum induced remarkable average reductions in worm burden (54.3%), liver eggs per gram (LEPG) load (59.8%) as well as egg granulomas size (66.5%) compared to PBS control group (P<0.01), which were significantly higher than those elicited by fractions of juvenile worm cells (JCFs) or fractions of juvenile worms (JWFs) (P<0.05). Non-cell components of worms (WNCs) showed no significant protection. In trial two, compared to PBS control group, significant protective effect was also observed for cultured juvenile worm cells (cJCs) from S. japonicum with 58.4% worm reduction and 68.1% LEPG reduction (P<0.01). However, cultured adult worms cells (cACs) showed significantly higher worm burden (P<0.05) and egg burden (P<0.01) when compared to cJCs. Immunological analysis of trial two revealed that cJCs engendered a Th1-biased mixed Th1/Th2 type of immune response while cACs elicited a Th2-type response. Our data indicated that immunization with both primary and cultured cells from S. japonicum juvenile worms provided high immunoprotection, for which the physical character of immunogens, stage-specific parasite and the type of immune response induced might be responsible, suggesting that vaccination with whole cells from S. japonicum larvae is a promising approach to produce protec- tive immunity against schistosomiasis.     

Identification of immunodominant Th1-type T cell epitopes from Schistosoma japonicum 28 kDa glutathione-S-transferase, a vaccine candidate

Th1-type cytokines produced by the stimulation of Th 1-type epitopes derived from defined schistosome-associated antigens are correlated with the development of resistance to the parasite infection. Schistosoma mansoni 28 kDa glutathione-S-transferase （Sm28GST）, a major detoxification enzyme, has been recognized as a vaccine candidate and a phase II clinical trial has been carried out. Sheep immunized with recombinant Schistosoma japonicum 28GST （Sj28GST） have shown immune protection against the parasite infection. In the present study, six candidate peptides （P1, P2, P3, P4, P7 and P8） from Sj28GST were predicted, using software, to be T cell epitopes, and peptides P5 and P6 were designed by extending five amino acids at the N-terminal and C-terminal of P1, respectively. The peptide 190-211 aa in Sj28GST corresponding to the Th1-type epitope （190-211 aa） identified from Sm28GST was selected and named P9. The nine candidate peptides were synthesized or produced as the fusion protein with thioredoxin in the pET32c（＋）/BL21（DE3） system. Their capacity to induce a Th1-type response in vitro was measured using lymphocyte proliferation, cytokine detection experiments and flow cytometry. The results showed that P6 （73-86 aa） generated the strongest stimulation effect on T cells among the nine candidate peptides, and drove the highest level of IFN-γ, and IL-2. Therefore, P6 is a functional Thl-type T cell epitope that is different from that in Sm28GST, and will be useful for the development of effective vaccines which can trigger acquired immunity against S. japonicum. Moreover, our strategy of identifying the Thl-type epitope by a combination of software prediction and experimental confirmation provides a convenient and cost-saving alternative approach to previous methods.     

日本血吸虫32kDa蛋白质基因在真核表达载体中的亚克隆

设计和合成特定寡核苷酸引物,TRIZOL提取日本血吸虫成虫RNA,RT-PCR法扩增日本血吸虫32kDa蛋白质(Sj32)基因编码序列,将扩增产物连接pGEM-T克隆载体,再亚克隆到真核表达载体pBKCMV中.结果RT-PCR法特异性扩增出Sj32编码基因片段,其大小约为1270bp,经双酶切、PCR鉴定表明所构建的质粒pGEM-Sj32和pBK-Sj32中含有目的基因.pBK-Sj32重组质粒的成功构建,为进一步表达Sj32及其在血吸虫病免疫诊断、免疫预防中的作用研究提供了条件.     

Cloning, expression and protective immunity evaluation of the full-length cDNA encoding succinate dehydrogenase iron-sulfur protein of Schistosoma japonicum

1071-bp fragment was obtained from the Schistosoma japonicum (Chinese strain) adult cDNA library after the 3' and 5' ends of the incomplete expression sequence tag (EST) of succinate dehydrogenase iron-sulfur protein of Schistosoma japonicum (SjSDISP) were amplified by the anchored PCR with 2pairs of primers designed according to the EST of SjSDISP and the sequence of multiclone sites of the library vector. Sequence analysis indicated that the fragment was a full-length cDNA with a complete open reading frame (ORF), encoding 278 amino acid residues. The fragment was cloned into prokaryotic expression vector pQE30, and subsequently sequenced and expressed in Escherichia coll.SDS-PAGE and Western-blot analyses showed that the recombinant protein was about 32 kD and could be recognized by the polyclonal antisera from rabbits immunized with Schistosoma japonicum adult worm antigen. Compared with the FCA controls, mice vaccinated with rSjSDISP (test) or rSjGST (positive control) all revealed high levels of specific antibody and significant reduction in worm burden, liver eggs per gram (LEPG), fecal eggs per gram (FEPG) and intrauterine eggs. These results suggest that SjSDISP may be a novel and partially protective vaccine candidate against schistosomiasis. In contrast to the worm burden reduction rate, the higher degree of egg reduction rate in the test group also suggested that SjSDISP vaccine may primarily play a role in anti-embryonation or anti-fecundity immunity.     

Cloning, expression and protective immunity evaluation of the full-length cDNA encoding succinate dehydrogenase iron-sulfur protein of Schistosoma japonicum

1071-bp fragment was obtained from the Schistosoma japonicum (Chinese strain) adult cDNA library after the 3′ and 5′ ends of the incomplete expression sequence tag (EST) of succinate dehydrogenase iron-sulfur protein of Schistosoma japonicum (SjSDISP) were amplified by the anchored PCR with 2 pairs of primers designed according to the EST of SjSDISP and the sequence of multiclone sites of the library vector. Sequence analysis indicated that the fragment was a full-length cDNA with a complete open reading frame (ORF), encoding 278 amino acid residues. The fragment was cloned into prokary- otic expression vector pQE30, and subsequently sequenced and expressed in Escherichia coli. SDS-PAGE and Western-blot analyses showed that the recombinant protein was about 32 kD and could be recognized by the polyclonal antisera from rabbits immunized with Schistosoma japonicum adult worm antigen. Compared with the FCA controls, mice vaccinated with rSjSDISP (test) or rSjGST (posi- tive control) all revealed high levels of specific antibody and significant reduction in worm burden, liver eggs per gram (LEPG), fecal eggs per gram (FEPG) and intrauterine eggs. These results suggest that SjSDISP may be a novel and partially protective vaccine candidate against schistosomiasis. In contrast to the worm burden reduction rate, the higher degree of egg reduction rate in the test group also sug- gested that SjSDISP vaccine may primarily play a role in anti-embryonation or anti-fecundity immunity.